Rocket Pharmaceuticals Reports Exit/Disposal Costs
Ticker: RCKTW · Form: 8-K · Filed: Jul 23, 2025 · CIK: 1281895
| Field | Detail |
|---|---|
| Company | Rocket Pharmaceuticals, Inc. (RCKTW) |
| Form Type | 8-K |
| Filed Date | Jul 23, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: restructuring, disposal, 8-K
TL;DR
Rocket Pharma filed an 8-K about exit costs - details TBD.
AI Summary
Rocket Pharmaceuticals, Inc. filed an 8-K on July 23, 2025, reporting on cost associated with exit or disposal activities. The filing does not specify any dollar amounts or specific details regarding these costs.
Why It Matters
This filing indicates potential restructuring or divestiture activities within Rocket Pharmaceuticals, which could impact future operations and financial performance.
Risk Assessment
Risk Level: medium — The filing mentions costs associated with exit or disposal activities, which can signal financial distress or strategic shifts that carry inherent risks.
Key Players & Entities
- Rocket Pharmaceuticals, Inc. (company) — Registrant
- July 23, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 001-36829 (file_number) — SEC File Number
- 9 Cedarbrook Drive, Cranbury, NJ 08512 (address) — Principal executive offices
- 646-440-9100 (phone_number) — Registrant's telephone number
FAQ
What specific activities are associated with the exit or disposal costs reported by Rocket Pharmaceuticals?
The filing does not provide specific details on the nature of the exit or disposal activities.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on July 23, 2025.
What is the principal executive office address for Rocket Pharmaceuticals?
The principal executive offices are located at 9 Cedarbrook Drive, Cranbury, NJ 08512.
What is the SEC file number for Rocket Pharmaceuticals?
The SEC file number is 001-36829.
What is the former name of Rocket Pharmaceuticals, Inc.?
The former name was Inotek Pharmaceuticals Corp.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 23, 2025 regarding ROCKET PHARMACEUTICALS, INC. (RCKTW).